On May 7, 2018, Impax Laboratories, Inc. combined with Amneal Pharmaceuticals, Inc. (NYSE:AMRX) to create a dynamic company powered by a robust U.S. generics business and growing branded franchise. Today, we are working to integrate our business into the new Amneal and are excited about our future as one company.

We conduct our business according to high legal and ethical business standards. Our commitment is defined by our Code of Conduct and is embraced enthusiastically by Amneal + Impax colleagues across our company.